Improving global access to medicines for non-communicable diseases

The Lancet Global Health

Volumn 2, Issue 10, 2014, Pages e561-e562

  Beran, David ^a,b   Perrin, Christophe ^c   Billo, Nils ^d   Yudkin, John S ^b,e  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b International Insulin Foundation   (United Kingdom)

^c International Union Against Tuberculosis and Lung Disease ^*  (France)

^d INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; INSULIN; NARCOTIC ANALGESIC AGENT; ESSENTIAL DRUG;

ACCESS TO INFORMATION; DRUG COST; DRUG INFORMATION; DRUG MANUFACTURE; DRUG MARKETING; DRUG SAFETY; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; FUNDING; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; LOWEST INCOME GROUP; NON COMMUNICABLE DISEASE; NOTE; PALLIATIVE THERAPY; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; QUALITY CONTROL; TRAINING; WORLD HEALTH ORGANIZATION; DEVELOPING COUNTRY; HEALTH; HEALTH CARE DELIVERY; SUPPLY AND DISTRIBUTION;

DEVELOPING COUNTRIES; DRUGS, ESSENTIAL; GLOBAL HEALTH; HEALTH SERVICES ACCESSIBILITY; HUMANS; WORLD HEALTH ORGANIZATION;

EID: 84907259055     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(14)70189-5     Document Type: Note

References (10)

1. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. Revised draft (version dated Feb 11, 2013) 2013, WHO, World Health Organization, Geneva.
2. Cameron A, Roubos I, Ewen M, et al. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bull World Health Org 2011, 89:412-421.
3. Mendis S, Fukino K, Cameron A, et al. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Org 2007, 85:279-288.
4. The world health report 2010. Health system financing: the path to universal coverage 2010, WHO, World Health Organization, Geneva.
5. Hogerzeil HV, Liberman J, Wirtz VJ, et al. Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. Lancet 2013, 381:680-689.
6. The important world of drug prequalification. Lancet 2004, 364:1830.
7. Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010, 376:1186-1193.
8. Billo N Asthma drug facility: from concept to reality. Int J Tuberc Lung Dis 2006, 10:709.
9. Measuring medicine prices, availability, affordability and price components 2008, WHO, HAIHAI, World Health Organization and Health Action International, Geneva and Amsterdam.
10. Beran D, Higuchi M How to investigate access to care for chronic noncommunicable diseases (NCDs) in low- and middle-income countries. Draft for field testing 2012, World Health Organization, Geneva.